Introduction {#Sec1}
============

Chronic kidney disease (CKD) affects older people at a higher rate compared with younger subjects. According to systematic reviews and analyses, the incidence of CKD has significantly increased with the improvement on the life span of the general population \[[@CR1]\]. Based on Chinese epidemiological surveys on CKD, the average age of patients with stage 3 CKD or higher is 63.6 years old. With an increase of 10 years in age, the risk of epidermal growth factor receptor (eGFR) is less than 60 ml/min per 1.73 m^2^, which represents the renal glomerular filtration rate, increasing by 1.74-fold \[[@CR2]\]. According to the US National Health and Nutrition Examination Survey, the incidences of phase 1 or 2 CKD were 2 %--3 % among people within the age of 20 to 39 years and 9 %--10 % among people above 70 years old, whereas those of phase 3 or 4 CKD were 0.2 %--0.7 % among people with the age range of 20 to 39 years old and 27.8 %--37.8 % among people above 70 years old \[[@CR3]\]. Tubulointerstitial fibrosis plays an important role in the course of CKD and is a typical characteristic of aged kidney tissues \[[@CR2], [@CR3]\]. Tumor growth factor-beta 1 (TGF-β1) is an important growth factor that induces epithelial-to-mesenchymal transition (EMT) and promotes tubulointerstitial fibrosis \[[@CR4]\].

Bone marrow mesenchymal stem cells (BM-MSCs) are a pluripotent cell population that can differentiate into various cell types such as fat, bone, muscle, and skin cells as well as show significant therapeutic effects against many diseases \[[@CR5]--[@CR7]\]. It has been recently found that BM-MSCs change accordingly with the age of an individual \[[@CR8]--[@CR10]\]. With aging, BM-MSCs decrease in number \[[@CR11], [@CR12]\], and the functional factors they secrete may also change \[[@CR12]--[@CR14]\]. Microvesicles (MVs) are small-particle exosomes that are secreted by BM-MSCs and contain a number of bioactive substances such as proteins, lipids, mRNA, and microRNA (miRNA). These also have good therapeutic effects against acute and chronic diseases \[[@CR15]--[@CR17]\]. miRNAs are important genetic regulatory factors of BM-MSC-MVs that identify target mRNAs through base pairing. Moreover, based on the degree of complementarity, miRNAs can guide silencing complexes to degrade target mRNAs or downregulate the expression of mRNAs. Previous studies have shown that miRNAs are closely linked to the occurrence of diseases and the aging process \[[@CR18]--[@CR20]\]. However, information on differences in miRNA expression in BM-MSC-MVs between young and elder individuals and whether these differences can further promote renal fibrosis and aging of kidney is unknown. The present study aimed to analyze differences in miRNA expression of BM-MSC-MVs between young or elder rats as well as the effect of differentially expressed miRNAs on TGF-β1-mediated EMT of HK2 cells in relation to the pathogenesis of renal fibrosis in aged tissues.

Methods {#Sec2}
=======

Cell culture and identification of BM-MSCs {#Sec3}
------------------------------------------

Animal welfare and experimental procedures were all carried out in accordance with the Guide for the Care and Use of Laboratory Animals (Ministry of Science and Technology of China, 2006) and were approved by the animal ethics committee of the General Hospital of the People's Liberation Army. BM-MSCs were extracted from 3- and 24-month-old Fisher344 rats \[[@CR16]\]. The isolated primary BM-MSCs were cultured in complete medium (Cyagen Bioscience Inc., Santa Clara, CA, USA). After the cells were passaged to P2, BM-MSCs were identified by flow cytometry by using cell surface markers, CD44, CD105, CD146, and CD45 (BioLegend Inc., San Diego, CA, USA).

Proliferation, migration, and differentiation of BM-MSCs {#Sec4}
--------------------------------------------------------

### BM-MSC proliferation assay {#Sec5}

Both P2 BM-MSCs from young and elder rats were counted after trypsinization by using 0.25 % trypsin (Corning, Corning, NY, USA), and then approximately 10,000 cells were resuspended in 100 μl of media and seeded onto each well of a 96-well plate. After culturing for 4 days, each well was supplemented with 10 μl of a cck-8 solution (Dojindo Inst. Biotech, Shanghai, China). The plate was cultured for 3 h in an incubator. The absorbance at a wavelength of 450 nm was measured by using a microplate reader. Each group had five replicate experimental sets.

### BM-MSC migration assay {#Sec6}

Polycarbonate membrane transwell inserts (8 μm) were used (Corning). Before cell inoculation, upper transwell chambers were equilibrated for 30 min by using serum-free RPMI 1640 medium (Corning). Then in the uncoated upper chambers, 1 × 10^5^ P2 BM-MSCs, which had been resuspended in serum-free RPMI 1640 medium, were inoculated. In the lower chambers, normal medium containing 10 % serum (Cyagen Bioscience Inc.) was added. After incubating for 24 h, cells that had not migrated across the polycarbonate membranes were gently wiped off. Then the cells on the underside of the membranes were fixed for 30 min with 4 % formaldehyde and stained with crystal violet (Beyotime Institute of Biotechnology, Jiangsu, China). Cells that migrated across the polycarbonate membrane were imaged and counted by using an inverted microscope.

### BM-MSC osteogenic differentiation assay {#Sec7}

When the cells were 60 %--70 % confluent, the complete medium was replaced with osteogenic and induction medium (Cyagen Bioscience Inc.). After incubation for 3--4 weeks, bone nodules were stained with Alizarin Red S.

### BM-MSC adipocyte differentiation assay {#Sec8}

When the cells were 70 %--80 % confluent, the complete medium was replaced with an adipogenic induction medium (Cyagen Bioscience Inc.). After incubation for 2 weeks, lipid droplets were stained by using Oil Red O.

Extraction and identification of MVs {#Sec9}
------------------------------------

Cells were starved overnight in serum-free medium supplemented with 0.5 % bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA) prior to collection of MVs. Cell debris was removed from the supernatant after centrifugation at 2000 × *g* for 20 min. The supernatant was collected and centrifuged at 100,000 × *g* at 4 °C for 1 h by using a high-speed refrigerated centrifuge (CP100WX; Hitachi, Tokyo, Japan). The pellet was resuspended in serum-free RPMI 1640 medium, which was again centrifuged at 100,000 × *g* at 4 °C for 1 h. The final pellet was considered to consist of MVs \[[@CR17]\]. The collected MVs were treated with phosphate-buffered saline (PBS) and fluorescein isothiocyanate (FITC) or phycoerythrin (PE)/CY7-labeled anti-CD44, CD29, and alpha 4-integrin antibodies (BioLegend Inc.). Murine IgG labeled with FITC or PE/CY7 (BioLegend Inc.) was used as a negative control. Flow cytometry was used to identify cell surface markers.

SA-β-Gal staining {#Sec10}
-----------------

A senescence-associated beta-galactosidase (SA-β-Gal) staining kit was used (Beyotime Institute of Biotechnology). P2 BM-MSCs were seeded onto a six-well plate. When cells reached 70 % confluency, the medium was aspirated and the cells were washed twice with PBS. The cells were subsequently fixed with 4 % formaldehyde for 30 min and then stained for 16 h at 37 °C with an SA-β-Gal staining reagent. Positively stained (blue) cells were counted by using an inverted microscope, and the positive rates between the young and elder groups were compared.

Microarray analysis of miRNAs in BM-MSC-MVs {#Sec11}
-------------------------------------------

The technology of miRCURY LNA Array (version 18.0) (Exiqon, Vedbaek, Denmark) was adopted. RNA was extracted and purified from BM-MSC-MVs of both young and elder groups. With an Exiqon miRCURY Hy3/Hy5 Power Labeling Kit, miRNAs were fluorescently labeled and then hybridized in an miRCURY LNA Array Station (version 18.0). A GenePix 4000B microarray reader was used to measure chip fluorescence intensity. Then the fluorescence intensity was converted to raw numeric data by using GenePix pro version 6.0. Triplicates were set up for both young and elder groups. Signals with fluorescence intensities of 30 or above were selected for group analysis. The raw signals were normalized with the median fluorescence intensity of each chip. With the normalized signals, different expression levels of miRNAs between the young and elder groups were calculated. The statistical significance of the differences in miRNA expression between both groups was calculated by using the *t* test. miRNAs with 1.5-fold or above expression difference and *P* values of less than 0.05 were selected and defined as those showing significant differential expression. The microarray data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) public repository and are accessible under GEO Series accession number GSE72198.

Verification of mRNA differential expression in BM-MSC-MVs and sera {#Sec12}
-------------------------------------------------------------------

Blood from five 3-month-old and five 24-month-old Fisher344 rats was collected from the orbital sinus. After centrifugation at 3000 × *g* for 15 min, 100 μl of serum was collected from the supernatant. Based on methods earlier described, BM-MSCs were extracted and cultured, and the derived MVs were collected from the 10 rats. Total RNAs in sera and MVs were extracted by using an Exiqon miRCURY RNA Isolation Kit. The corresponding cDNAs were synthesized by using SYBR PrimeScript miRNA reverse transcription-polymerase chain reaction (RT-PCR) Kit (Takara, Tokyo, Japan). Lastly, an ABI-Prism 7500 Sequence Detection System (Applied Biosystems, Waltham, MA, USA) and SYBR PrimeScript miRNA RT-PCR Kit (Takara) were used to detect the expression level of specific miRNAs (miR-344a, miR-294, miR-872-3p, miR-133b-3p, and miR-423-3p) and the loading control, miR-191.

TGF-β1 stimulation and miRNA transfection {#Sec13}
-----------------------------------------

HK2 cells (American Type Culture Collection, Manassas, VA, USA) were cultured in 10 % fetal bovine serum (FBS) Dulbecco's modified Eagle's medium/F12 (DMEM/F12) medium (Corning). When the cells reached 50 % confluency, serum-free DMEM/F12 medium was used to synchronize the cells for 18 h. The HK2 cells were incubated with recombinant human TGF-β1 (PeproTech Inc., Rocky Hill, NJ, USA) at a concentration of 8 ng/ml for 48 h to induce fibrosis with young MV (10^5^ young MSCs released overnight) or old MV (10^5^ old MSCs released overnight) treatment. For the miRNA transfection groups, miR-344a, miR-294, miR-872-3p, miR-133b-3p, and miRNA mimic control (GeneCopoeia Inc., Rockville, MD, USA) were transfected into the synchronized HK2 cells in accordance with the instructions of the jetPRIME® transfection reagent (Polyplus Transfection Inc., USA). Approximately 24 h after transfection, the medium was replaced with 10 % FBS DMEM/F12 medium (Corning, Shanghai, China) containing 8 ng/ml of TGF-β1 (PeproTech Inc.) and then incubated for 48 h.

Western blot analysis {#Sec14}
---------------------

The HK2 cells were lysed with RIPA lysis buffer, and then 40 μg of the total protein extract was loaded into each well and separated by using 8 % polyacrylamide (SDS-PAGE) protein gel electrophoresis. The proteins were transferred onto nitrocellulose membranes. The membranes were blocked in 1× casein (Sigma-Aldrich) for 1 h, and the membranes were incubated with the following primary antibodies at 4 °C overnight:i.Rabbit monoclonal anti-E-cadherin (1:800 dilution; Biogot Biotechnology Co. Ltd., Nanjing, China)ii.Rabbit monoclonal anti-alpha-smooth muscle actin (anti-α-SMA) (1:500 dilution; Abcam, Cambridge, MA, USA)iii.Anti-β-actin (1:5,000 dilution; Beyotime Institute of Biotechnology).

After excess primary antibodies were washed off, the membranes were incubated with secondary antibodies (Beyotime Institute of Biotechnology) diluted in 1:1000 for 2 h at room temperature. The target band was detected chemiluminescently by using an enhanced chemiluminescence (ECL) Western Blotting kit (Applygen Technologies Inc., Beijing, China). While β-actin was used as internal control, the relative expression levels of E-cadherin and α-SMA were calculated in each experimental group.

Immunofluorescence {#Sec15}
------------------

HK2 cell suspensions were seeded onto autoclaved glass coverslips placed in six-well plates (10^5^ cells per well). After overnight incubation at 37 °C in 5 % CO~2~, cells had adhered to the coverslips. After synchronization and transfection based on previous methods, 10 % FBS DMEM/F12 medium (Corning) with or without 8 ng/ml TGF-β1 (PeproTech Inc.) was used, and the cells were further incubated for 48 h. After fixing in 4 % paraformaldehyde (Beyotime Institute of Biotechnology) at room temperature for 15 min, the cells were permeabilized in 0.2 % Triton X-100 (Sigma-Aldrich) for 5 min and then blocked in 1× casein (Sigma-Aldrich) at room temperature for 30 min. Rabbit monoclonal anti-E-cadherin (1:100, Biogot Biotechnology Co. Ltd.) and anti-α-SMA (1:50; Abcam) primary antibodies were diluted and added to the coverslips and then incubated overnight at 4 °C. After washing with PBS, fluorescent anti-rabbit conjugated with CY3 or FITC secondary antibodies (1:400, Jackson ImmunoResearch Laboratories, Bar Harbor, ME, USA) were added and incubated for 2 h at room temperature. After washing with PBS, the coverslips were removed from the six-well plates and placed on a glass slide, and mounting medium containing 4ʹ,6-diamidino-2-phenylindole (DAPI) (ZSGB-BIO, Beijing, China) was added. Random fields were chosen under a fluorescence microscope (Olympus America Inc., Center Valley, PA, USA), and the expressions of E-cadherin and α-SMA in HK2 cells were observed.

Statistical analysis {#Sec16}
--------------------

Results were expressed as the mean ± standard deviation by using SPSS 17.0 software (IBM Corporation, Armonk, NY, USA). Differences between experimental groups were analyzed by using one-way analysis of variance. *P* values of less than 0.05 were considered statistically significant.

Results {#Sec17}
=======

Identification and senescence staining of BM-MSCs {#Sec18}
-------------------------------------------------

Figure S1 in Additional file [1](#MOESM1){ref-type="media"} shows that fewer BM-MSCs were extracted from an equal amount of bone marrow in older, 24-month-old rats compared with younger, 3-month-old rats. Moreover, under the same incubation conditions, we observed fewer adherent BM-MSCs in the older group than in the younger rats. In addition, the growth rate of BM-MSCs derived from young rats was significantly faster than those derived from older rats. With each additional passage of primary BM-MSCs derived from older rats, we observed slower and irregular cell growth, with wider intercellular spacing in BM-MSCs (Additional file [1](#MOESM1){ref-type="media"}). By using SA-β-Gal staining that detects senescent cells, we observed a higher positive staining rate in BM-MSCs from older rats than in BM-MSCs from younger rats (Additional file [2](#MOESM2){ref-type="media"}). According to the flow cytometry data, the expression of BM-MSC surface markers, including CD44, CD105, and CD146, was positive in both young and older rats, whereas the expression of CD45 was negative in both groups (Fig. [1a](#Fig1){ref-type="fig"}). Adhesion molecules, including CD44, CD29, and α4-integrin, which are expressed on the plasma membrane of BM-MSCs, were detected on the surface of BM-MSC-MVs from both young and elder rats (Fig. [1b](#Fig1){ref-type="fig"}). BM-MSCs from both young and elder rats had the capacity to differentiate into adipocytes and osteoblasts (Fig. [1c](#Fig1){ref-type="fig"}).Fig. 1Characterization of young and old MSCs as well as young and old MVs. **a** BM-MSCs from young and old Fisher344 rats were cultured to passage 3 and labeled with a FITC-coupled antibodies against CD44 and CD146 and a PE/Cy7-coupled antibody against CD45 and CD105 or immunoglobulin isotype control IgGs and analyzed by using FACS. **b** MVs from young and old MSCs were collected and labeled with FITC-coupled antibodies against CD44, a4-integrin, and PE/Cy7-coupled antibody against CD29 or immunoglobulin isotype control IgGs and analyzed by using FACS. **c** Representative photomicrographs show lipid inclusions with Oil Red O (*left*) and mineralization with alizarin red (*right*) in MSCs from young (*top*) and old rats (*bottom*). *FACS* fluorescence-activated cell sorting, *FITC* fluorescein isothiocyanate, *MSC* mesenchymal stem cell, *MV* microvesicle, *PE* phycoerythrin

Aged BM-MSCs show decreased proliferation and migration {#Sec19}
-------------------------------------------------------

BM-MSCs of older rats showed significantly slower growth rate *in vitro* than that of younger rats (Additional file [3](#MOESM3){ref-type="media"}a). In the transwell migration assay, compared with BM-MSCs derived from younger rats, the migration capacity of BM-MSCs from older rats also remarkably decreased, and this was likely due to aging (Additional file [3](#MOESM3){ref-type="media"}b).

Change in miRNA expression profiles in BM-MSC-MVs caused by aging {#Sec20}
-----------------------------------------------------------------

Compared with the younger group, 117 miRNAs from BM-MSC-MVs derived from older rats were differentially expressed, and 19 of them showed statistically significant changes (*P* \< 0.05): the expression levels of 14 miRNAs were upregulated and 5 were downregulated (Fig. [2a](#Fig2){ref-type="fig"}, [b](#Fig2){ref-type="fig"}). For significantly downregulated miRNAs on the microarray, the expression levels in MVs were verified by RT-PCR, and the results from both assays were in agreement. miR-344a, miR-133b-3p, miR-294, miR-423-3p, and miR-872-3p in BM-MSC-MVs from aged rats were downregulated, and the expression of miR-294 and miR-872-3p showed a significant decline (*P* \< 0.05) (Fig. [2c](#Fig2){ref-type="fig"}).Fig. 2Age-dependent changes in miRNA profiles of young and old MVs. **a** Expression of miRNAs in young and old MVs and mapping of hierarchic clustering of miRNAs and heatmap display of miRNA profiles. **b** Significant fold changes in miRNAs (fold change \> 1.5) in old MVs versus young MVs. Upregulated miRNAs were marked in *red*, and downregulated miRNAs are indicated in *green*. **c** RT-PCR analysis was used to validate the downregulated miRNAs in young and old MVs. **d** RT-PCR analysis was employed to validate the downregulated miRNAs in serum from young and old rats (\**P* \< 0.05; \*\**P* \< 0.01; n = 5). *miRNA* microRNA, *MV* microvesicle, *RT-PCR* reverse transcription-polymerase chain reaction

Expression of miRNAs in blood {#Sec21}
-----------------------------

Compared with younger rats, the serum levels of miR-344a, miR-133b-3p, miR-294, and miR-872-3p in aged rats decreased, and those of miR-133b-3p, miR-294, and miR-872-3p showed a significant decrease (*P* \< 0.05) (Fig. [2d](#Fig2){ref-type="fig"}).

Inhibition of TGF-β1-mediated EMT by BM-MSC-MV is weakened in older rats {#Sec22}
------------------------------------------------------------------------

BM-MSC-MVs derived from younger rats showed significant inhibitory effects on TGF-β1-mediated EMT in HK2 cells. The addition of BM-MSC-MVs from younger rats to TGF-β1 resulted in the stimulation of HK2 cells to reverse the downregulated E-cadherin expression and upregulated α-SMA expression (*P* \< 0.05 for both). On the other hand, BM-MSC-MVs derived from older rats did not show such effects (Fig. [3a](#Fig3){ref-type="fig"}, [b](#Fig3){ref-type="fig"}). These observations of EMT marker expression in HK2 cells subjected to various treatments were further confirmed by immunofluorescence staining (Figs. [4a](#Fig4){ref-type="fig"}--[d](#Fig4){ref-type="fig"} and [5a](#Fig5){ref-type="fig"}--[d](#Fig5){ref-type="fig"}).Fig. 3Effect of MVs and miRNAs on the inhibitory effect of TGF-β1 on the EMT in HK2 cells. **a, c** Western blot analysis of E-cadherin and α-SMA expression in HK2 cells under TGF-β1 stimulation co-cultured with Y-MV /O-MV or pre-transfection with miR-872, miR-344, miR-294, miR-133b -3p, and miR-control mimic. β-actin was used as internal control. **b, d** Quantification of E-cadherin and α-SMA protein levels in HK2 cells from each experimental group. \*\**P* \< 0.05; n =3. *α-SMA* alpha-smooth muscle actin, *EMT* epithelial-mesenchymal transition, *MV* microvesicle, *TGF-β1* transforming growth factor-beta 1Fig. 4Immunocytochemical analysis of E-cadherin staining: Representative images of anti-E-cadherin staining in HK2 cells from each experimental group. The *green* staining shows the expression of E-cadherin in normal HK2 cells that were (**a**) treated with TGF-β1 (**b**) or co-cultured with Y-MV (**c**) or Old-MV (**d**). It also indicated the expression of E-cadherin in HK2 cells treated with TGF-β1 but pre-transfected with miR-872, miR-344, miR-294, miR-133b-3p, and miR-control mimic (**e-i**). *TGF-β1* transforming growth factor-beta 1Fig. 5Immunocytochemical staining of α-SMA in HK2 cells from each experimental group. The *red* staining shows the expression of α-SMA in normal HK2 cells that were (**a**) treated with TGF-β1 (**b**) or co-cultured with Y-MV (**c**) or Old-MV (**d**). It also indicated the expression of α-SMA in HK2 cells treated with TGF-β1 but pre-transfected with miR-872, miR-344, miR-294, miR-133b-3p, and miR-control mimic (**e--i**). *α-SMA* alpha-smooth muscle actin, *TGF-β1* transforming growth factor-beta 1

Effects of miRNA downregulated in elder rat BM-MSC-MVs on TGF-β1-mediated EMT {#Sec23}
-----------------------------------------------------------------------------

HK2 cells were initially transfected with miR-344a, miR-294, miR-872 -3p, miR-133b-3p, and miRNA mimic control and then incubated in a medium containing 8 ng/ml TGF-β1 for 48 h. Compared with non-transfected HK2 cells, the expression level of α-SMA significantly decreased in HK2 cells transfected with miR-344a, miR-294, and miR-133b-3p (*P* \< 0.05), and the expression level of E-cadherin significantly increased in HK2 cells transfected with miR-294 and miR-133b-3p (*P* \< 0.05). Meanwhile, HK2 cells transfected with miR-872-3p exhibited no significant changes (Fig. [3c](#Fig3){ref-type="fig"}, [d](#Fig3){ref-type="fig"}). We also validated these results by immunofluorescence staining, which showed that HK2 cells without TGF-β1 stimulation displayed high expression of E-cadherin and low expression of α-SMA. After TGF-β1 stimulation, HK2 cells presented lower expression of E-cadherin and higher expression of α-SMA. Moreover, miR-344a, miR-294, and miR-133b-3p weakened the upregulation of α-SMA and inhibited the downregulation of E-cadherin in HK2 cells induced by TGF-β1 (Figs. [4e](#Fig4){ref-type="fig"}-[i](#Fig4){ref-type="fig"} and [5e](#Fig5){ref-type="fig"}-[i](#Fig5){ref-type="fig"}).

Discussion {#Sec24}
==========

Renal interstitial fibrosis is a characteristic pathology of aging kidneys and the basis of CKD progression. EMT of renal tubules is the leading cause of renal interstitial fibrosis. Several studies have shown that TGF-β1 enhances EMT through a variety of mechanisms \[[@CR21]--[@CR23]\]. In addition, various studies have demonstrated that BM-MSCs participate in renal tissue repair. Morigi et al. \[[@CR24]\] showed that BM-MSCs can improve kidney functions, and BM-MSCs are the primary cell population involved in renal tubular and functional repair. Other recent investigations have also shown that BM-MSCs can reduce renal damage through paracrine activity \[[@CR25]--[@CR27]\].

MVs are small circular diaphragms (diameter of 100 nm to 1 μm) shed from the cell surface or released from cellular compartments. MVs contain proteins, enzymes, mRNA, and miRNA and may participate in tissue damage repair through paracrine activity \[[@CR15], [@CR17], [@CR27]\]. Camussi et al. \[[@CR15]\] revealed that both BM-MSCs and BM-MSC-MVs promote morphological restoration and renal function maintenance in animals with renal ischemia-reperfusion or unilateral nephrectomy. MVs secreted by BM-MSCs can enter the damaged kidney cells and play a role in kidney repair. Cantaluppi et al. \[[@CR28]\] also observed that MVs in rats possessed a repair function for renal ischemia-reperfusion injury. However, pre-treatment with an efficient miRNA blocker resulted in a reduction in repair function, suggesting that MVs can transfer miRNAs to repair damaged kidneys.

In eukaryotes, miRNAs play an extremely important role in organ development and maturation as well as the pathogenesis and progression of disease \[[@CR29]\]. Previous studies have shown that in fibrotic renal tissues the expressions of both miR-200 family and E-cadherin are significantly downregulated and that exogenous miR-200 could reduce renal fibrosis \[[@CR30], [@CR31]\]. Pre-transfection of the miR-200 family can reverse TGF-β1-mediated EMT in tubular epithelial cells \[[@CR30], [@CR32], [@CR33]\]. Through the regulation of Tgfbr2 and Gsk3-beta, miR-294/302 can inhibit TGF-beta and GSK3 pathways. On the other hand, miR-294/302 can indirectly inhibit Tgfbr2 as well as EMT of embryonic stem cells \[[@CR34]\]. Liu et al. discovered that, as a downstream gene of fibrotic TGF-β/Smad3 pathway, miR-133 can negatively regulate TGF-β/Smad3 \[[@CR35]\]. Along with physiological aging, BM-MSCs also age, and the cellular molecules these secrete significantly decrease or even disrupt secretion. Expression profiles of miRNAs can also significantly change with age, and its functions against diseases can decrease or become ineffective \[[@CR36], [@CR37]\].

In the present study, we found that the number of BM-MSCs derived from 24-month-old rats was significantly lower, displayed a senescent phenotype, and had a markedly slower *in vitro* proliferation rate compared with that observed in 3-month-old rats. Furthermore, these aged BM-MSCs showed irregular growth with increased cellular spacing, and their migration ability was significantly weaker. We also observed significant differences in miRNA expression of BM-MSC-MVs between younger and older rats. Compared with younger rats, five miRNAs in BM-MSC-MVs---miR-344a, miR-133b-3p, miR-294, miR-423-3p, and miR-872-3p---were significantly reduced in older rats. Additionally, compared with MVs from younger rats, the inhibitory effects of MVs from older rats on TGF-β1-induced EMTs were significantly reduced. We also observed that miR-133b-3p and miR-294, which were downregulated in older rats, imparted significant inhibitory effects on TGF-β1-induced EMT. Our data therefore suggested that the downregulation of miR-133b-3p and miR-294 in older rats may be an important cause of suppression of TGF-β1-induced EMT in aged rats.

In recent years, studies have shown that changes in body environment affect aging of organs. Through the establishment of Siamese animal models such as young and older rats, we observed that learning and memorization were enhanced in older rats but that these were weakened in younger rats. With injection of serum from older rats, younger rats presented brain aging phenotypes. Conversely, injection of serum from younger rats resulted in the alleviation of the brain aging phenotype in older rats \[[@CR38]\]. In the young-elderly rat model, cardiac hypertrophy of aged hearts was significantly less than that of the elder-elder rat model, and cardiac function significantly improved \[[@CR39]\]. In addition, in the young-elderly rat model, aged muscles, liver, neural stem/progenitor cells, and ovarian follicles were activated, and the regeneration capacity of tissues and organs was enhanced \[[@CR40]--[@CR42]\]. The miRNAs contained in BM-MSC-MVs can be released into blood circulation, where they are converted into circulating miRNAs that possess the ability to change the internal environment, and ultimately impart systemic effects. Our current experimental results showed that miRNAs that were downregulated in MVs from older rats also exhibited a comparatively low level in serum, suggesting that by secreting MVs and changing miRNA expression, BM-MSCs changed the body environment during the aging process. In older rats, the level of secreted miR-133b-3p and miR-294 decreased. Their levels in serum were also low and this may be an important factor in causing renal EMT and renal aging.

In the present study, we confirmed that, in older rats, the inhibitory effects of BM-MSC-MVs on TGF-β1-induced EMT had weakened, and this might be related to the decrease in the levels of miR-133b-3p and miR-294. However, the target genes, regulatory mechanisms, and signaling pathways of miR-133b-3p and miR-294 currently remain unclear and should be investigated in future studies.

Conclusions {#Sec25}
===========

The present study observed that the inhibitory effect of BM-MSC-MVs on TGF-β1-mediated HK2 cell EMT was weaker in older rats than in younger rats. Moreover, miR-133b-3p and miR-294, which were downregulated in BM-MSC-MVs and serum of older rats, could remarkably inhibit TGF-β1-mediated EMT in HK2 cells. These findings suggest that the downregulated miR-133b-3p and miR-294 in older rats play important roles in causing renal EMT and renal aging.

Additional files {#Sec26}
================

Additional file 1:**Cell morphology and population size in young and old MSCs.** Representative phase-contrast micrographs of cultured BM-MSCs derived from young (*bottom*) and old rats (*top*) of the P~0~, P~1~, and P~2~ generations. *BM-MSC* bone marrow mesenchymal stem cell, *MSC* mesenchymal stem cell. (DOC 2450 kb)Additional file 2:**SA-β-gal expression in young and old MSCs.** **a** SA-β-gal staining (×100). Compared with the Y-MSC group, the number of SA-β-gal-positive cells in the O-MSC group clearly increased. **b** Quantification of SA-β-gal-positive cells. The number of SA-β-gal-positive cells was determined by screening 500 random cells under a phase-contrast microscope. The number of SA-β-gal-positive cells in the O-MSC group was significantly higher than that in the Y-MSC group (\*\**P* \< 0.01; n = 5). *MSC* mesenchymal stem cell, *SA-β-gal* senescence-associated beta-galactosidase. (DOC 2015 kb)Additional file 3:**The proliferation and migration ability of young and old MSCs.** **a** CCK-8 assay shows that the proliferation of the MSCs was not significantly different between the young and old MSCs on days 1 and 2. The absorbance value in the old MSCs was significantly lower than that in the young MSCs on days 3 and 4. **b** The number of transferred MSCs in the young group (*top*) was significantly higher than that in the old group (*bottom*). (\**P* \< 0.05; n = 5). *MSC* mesenchymal stem cell. (DOC 2433 kb)
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